Incannex Healthcare Inc. (IXHL) vs Rockwell Medical, Inc. (RMTI)

Incannex Healthcare Inc. and Rockwell Medical, Inc. are both Drug Manufacturers Specialty & Generic companies. Incannex Healthcare Inc. and Rockwell Medical, Inc. are of similar size ($30.6M and $28.5M). Incannex Healthcare Inc. has the higher net margin (0.00% vs −7.33%) and the higher return on invested capital (0.00% vs −14.6%). Across the 17 metrics below, Incannex Healthcare Inc. leads on 9 and Rockwell Medical, Inc. on 8.

Valuation

Metric IXHL RMTI Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 16.88 0.44 2.08
P/B 0.39 0.87 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA 1.65 n/m 12.22
EV/Sales (24.08) 0.21 2.87
Earnings yield (75.75%) (17.40%) (15.94%)
Free cash flow yield (48.87%) (3.22%) 0.00%

Profitability

Metric IXHL RMTI Drug Manufacturers Specialty & Generic median
Gross margin (0.10%) 17.71% 53.51%
Operating margin 0.00% (6.52%) 0.00%
Net margin 0.00% (7.33%) (2.45%)
Free cash flow margin 0.00% 2.47% 0.00%
Return on equity (47.80%) (15.53%) (0.80%)
Return on assets (41.32%) (9.32%) (1.67%)
Return on invested capital 0.00% (14.58%) 0.00%

Growth

Metric IXHL RMTI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (21.12%) 5.22%
EPS growth (last fiscal year) 95.91% (870.87%) 42.91%
Revenue growth, 5-year CAGR (29.64%) 2.17% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IXHL RMTI Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.26 0.04
Current ratio 48.81 3.25 2.41
Net debt to EBITDA 2.97 7.40 1.01

Dividend

Metric IXHL RMTI Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric IXHL RMTI Drug Manufacturers Specialty & Generic median
Market cap 28.47m 30.64m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack